NHS Greater Glasgow and Clyde is an NHS board in West Central Scotland, created from the amalgamation of NHS Greater Glasgow and part of NHS Argyll and Clyde on 1 April 2006.

During the past decade, NHS Greater Glasgow and Clyde conducted 97 clinical trials. In the 10-year time frame, 97 clinical trials started and 15 clinical trials were completed, i.e. on average, 15.5% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 11 clinical trials were completed. i.e. 26.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NHS Greater Glasgow and Clyde" #1 sponsor was "NHS Greater Glasgow and Clyde" with 30 trials, followed by "Pfizer" with 6 trials sponsored, "Gilead Sciences" with 5 trials sponsored, "University of Dundee" with 5 trials sponsored and "ADC Therapeutics S.A." with 5 trials sponsored. Other sponsors include 59 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NHS Greater Glasgow and Clyde" #1 collaborator was "University of Glasgow" with 26 trials as a collaborator, "NHS Greater Glasgow and Clyde" with 11 trials as a collaborator, "NHS Lothian" with 6 trials as a collaborator, "University College London Hospitals" with 4 trials as a collaborator and "Cancer Research UK" with 3 trials as a collaborator. Other collaborators include 144 different institutions and companies that were collaborators in the rest 121 trials.

According to Clinical.Site data, the most researched conditions in "NHS Greater Glasgow and Clyde" are "Stroke" (4 trials), "Ulcerative Colitis" (4 trials), "Chronic Obstructive Pulmonary Disease" (3 trials), "Crohn's Disease" (3 trials) and "Dementia" (3 trials). Many other conditions were trialed in "NHS Greater Glasgow and Clyde" in a lesser frequency.

Most popular intervention types in "NHS Greater Glasgow and Clyde" are "Drug" (52 trials), "Other" (23 trials), "Behavioral" (15 trials), "Biological" (6 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Filgotinib" (4 trials), "Rituximab" (3 trials), "Cetrelimab" (2 trials) and "Loncastuximab Tesirine" (2 trials). Other intervention names were less common.

The vast majority of trials in "NHS Greater Glasgow and Clyde" are 102 trials for "All" genders, 6 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 42 active trials in "NHS Greater Glasgow and Clyde". 2 are not yet recruiting, 26 are recruiting, 12 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 43 completed trials in NHS Greater Glasgow and Clyde, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in NHS Greater Glasgow and Clyde, 2 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 43 trials that are defined as “Not Applicable".

NHS Greater Glasgow and Clyde has several departments that took part in Clinical trials: "Queen Elizabeth National Spinal Injuries Unit" - 13 trials, "Edinburgh Cancer Centre at Western General Hospital" - 55 trials, "Highland Diabetes Institute" - 6 trials, "Dundee Dental Hospital" - 5 trials, "Beatson West of Scotland Cancer Centre" - 398 trials, "Department of Anaesthesia, Ninewells Hospital & Medical School" - 2 trials, "Tayside Children's Hospital" - 2 trials, "Western Infirmary (Epilepsy)" - 2 trials